PubMed Health⌕ Search

PubMed · 8973838

The black reaction.

Abstract

Camillo Golgi (1843-1926) invented the black reaction in 1873, when he was head physician at the hospice for old people in Abbiategrasso, near Milan. Unlike the procedures that were available before its invention, the black reaction was able to reveal neurons in their entirety, i.e., with all their processes. This weighty event at first passed unnoticed. The first stirring of interest in the black reaction outside Italy began in 1885. The reasons the Golgi technique took so long to receive wide international attention are here analyzed. After it became known, the black reaction was widely employed for almost 30 years, during which time it was responsible for bringing about major advances in our knowledge of the microscopic anatomy of the nervous system, as well as in other fields of study. A number of results obtained by other researchers with the black reaction were vitally important for establishing the neuron theory. In the period between the two World Wars, the Golgi technique was almost forgotten, but returned in vogue once more around the middle of the 20th century following the introduction of the electron microscope to neurocytological research. One-hundred and twenty years after its invention, the black reaction is still widely employed, not only in combination with electron microscopy, but also as an autonomous technique for light microscope studies on the organization of the nervous system in normal conditions and after experimental manipulations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E Pannese. 1996. The black reaction.. https://doi.org/10.1016/s0361-9230(96)00177-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗